Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
49.9M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
26.3M
-
Shares change
-
+1.3M
-
Total reported value, excl. options
-
$440M
-
Value change
-
+$21.7M
-
Number of buys
-
37
-
Number of sells
-
-10
-
Price
-
$16.73
Significant Holders of HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) as of Q4 2022
60 filings reported holding HLVX - HilleVax, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 49.9M outstanding shares and own 52.77% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (9.76M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.69M shares), Abingworth LLP (1.84M shares), RA CAPITAL MANAGEMENT, L.P. (1.76M shares), BRAIDWELL LP (1.62M shares), FRANKLIN RESOURCES INC (1.25M shares), T. Rowe Price Investment Management, Inc. (1.21M shares), BlackRock Inc. (1.03M shares), VANGUARD GROUP INC (701K shares), and StepStone Group LP (677K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.